[Meningitis caused by Streptococcus pneumoniae serotype 7a in an infant vaccinated with two doses of 13-valent pneumococcal conjugate vaccine: a case study].
Méningite à
13-valent pneumococcal conjugate vaccine
Streptococcus pneumoniae serotype 7A
lumbar puncture
meningitis
Journal
The Pan African medical journal
ISSN: 1937-8688
Titre abrégé: Pan Afr Med J
Pays: Uganda
ID NLM: 101517926
Informations de publication
Date de publication:
2019
2019
Historique:
received:
13
01
2019
accepted:
19
04
2019
entrez:
18
7
2019
pubmed:
18
7
2019
medline:
25
7
2019
Statut:
epublish
Résumé
Pneumococcal meningitis is a global scourge. It is a major cause of morbidity and mortality. In Morocco, 13-valent pneumococcal conjugate vaccine (PCV13) was introduced into the National Immunization Program in October 2010 according to the immunization schedule 2 + 1 and replaced by PCV10 in July 2012, according to the same schedule. Despite the use of the PCV13, which is essential in the fight against pneumococcal disease, the emergence of new non-vaccine serotypes always results in meningitis in children, causing serious sequelae. We report the case of an infant vaccinated with two doses of PCV13 with meningitis caused by Streptococcus pneumoniae serotype 7a. The peculiarity of this case study lies in pneumococcal meningitis due to Streptococcus pneumoniae serotype 7a not included in the PCV13 in an infant immunized by 2 doses of PCV13. We here insist on the need and the importance of an observatory for pneumococcal meningitis and of a wide epidemiological study in order to determine the serotypes in Morocco after the introduction of PCV13 and then of PCV10.
Identifiants
pubmed: 31312315
doi: 10.11604/pamj.2019.32.203.18157
pii: PAMJ-32-203
pmc: PMC6620076
doi:
Substances chimiques
13-valent pneumococcal vaccine
0
Pneumococcal Vaccines
0
Types de publication
Case Reports
Langues
fre
Pagination
203Déclaration de conflit d'intérêts
Les auteurs ne déclarent aucun conflit d'intérêts.
Références
J Infect Dis. 2014 Oct 1;210(7):1001-11
pubmed: 24719477
MMWR Recomm Rep. 2010 Dec 10;59(RR-11):1-18
pubmed: 21150868
PLoS One. 2013;8(1):e51460
pubmed: 23365635
PLoS One. 2016 Dec 12;11(12):e0166736
pubmed: 27941979
Pediatr Infect Dis J. 2015 Oct;34(10):e260-3
pubmed: 26181894
Lancet. 2013 Jan 19;381(9862):214-22
pubmed: 23158882
BMC Pediatr. 2017 Apr 27;17(1):114
pubmed: 28449653
Wkly Epidemiol Rec. ;92(48):729-47
pubmed: 29192459
Indian J Pediatr. 2010 Dec;77(12):1387-91
pubmed: 20844989
PLoS One. 2013 Sep 23;8(9):e74906
pubmed: 24086394
Arch Pediatr. 2011 Dec;18(12):1265-70
pubmed: 21978670
Clin Pract. 2013 Mar 25;3(1):e11
pubmed: 24765491
Vaccine. 2015 Jan 3;33(2):359-66
pubmed: 25448105
Arch Pediatr. 2008 Jun;15(5):543-4
pubmed: 18582666
Vaccine. 2012 Dec 31;30 Suppl 6:G46-50
pubmed: 23228358
Wkly Epidemiol Rec. 2012 Apr 6;87(14):129-44
pubmed: 24340399
Clin Case Rep. 2016 Sep 22;4(11):1023-1025
pubmed: 27830065
Int J Infect Dis. 2015 Nov;40:95-101
pubmed: 26434380